{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:50:08Z","timestamp":1781538608511,"version":"3.54.5"},"reference-count":85,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000268","name":"BBSRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.tips.2021.05.003","type":"journal-article","created":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T16:37:19Z","timestamp":1622306239000},"page":"700-713","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Targeting KNa1.1 channels in KCNT1-associated epilepsy"],"prefix":"10.1016","volume":"42","author":[{"given":"Bethan A.","family":"Cole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Clapcote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Muench","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Lippiat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2021.05.003_bb0005","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00439-020-02199-3","article-title":"The Human Gene Mutation Database (HGMD\u00ae): optimizing its use in a clinical diagnostic or research setting","volume":"139","author":"Stenson","year":"2020","journal-title":"Hum. Genet."},{"key":"10.1016\/j.tips.2021.05.003_bb0010","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1002\/cne.23934","article-title":"Differential distribution of the sodium-activated potassium channels slick and slack in mouse brain","volume":"524","author":"Rizzi","year":"2016","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.tips.2021.05.003_bb0015","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/cne.10439","article-title":"Localization of the Slack potassium channel in the rat central nervous system","volume":"454","author":"Bhattacharjee","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.tips.2021.05.003_bb0020","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1523\/JNEUROSCI.5978-08.2009","article-title":"The N-terminal domain of Slack determines the formation and trafficking of Slick\/Slack heteromeric sodium-activated potassium channels","volume":"29","author":"Chen","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2021.05.003_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2020.00001","article-title":"The epilepsy of infancy with migrating focal seizures: identification of de novo mutations of the KCNT2 gene that exert inhibitory effects on the corresponding heteromeric KNa 1.1\/KNa 1.2 potassium channel","volume":"14","author":"Mao","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.tips.2021.05.003_bb0030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.brainres.2004.07.017","article-title":"Sodium-activated potassium conductance participates in the depolarizing afterpotential following a single action potential in rat hippocampal CA1 pyramidal cells","volume":"1023","author":"Liu","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.tips.2021.05.003_bb0035","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1152\/jn.00695.2002","article-title":"Na+-activated K+ current contributes to postexcitatory hyperpolarization in neocortical intrinsically bursting neurons","volume":"89","author":"Franceschetti","year":"2003","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.tips.2021.05.003_bb0040","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1523\/JNEUROSCI.5308-06.2007","article-title":"Slack and Slick K(Na) channels regulate the accuracy of timing of auditory neurons","volume":"27","author":"Yang","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2021.05.003_bb0045","doi-asserted-by":"crossref","first-page":"11541","DOI":"10.18632\/aging.102553","article-title":"The local translation of KNa in dendritic projections of auditory neurons and the roles of KNa in the transition from hidden to overt hearing loss","volume":"11","author":"Lee","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.tips.2021.05.003_bb0050","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1038\/s41598-019-39119-z","article-title":"Sodium-activated potassium channels shape peripheral auditory function and activity of the primary auditory neurons in mice","volume":"9","author":"Reijntjes","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2021.05.003_bb0055","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1113\/JP278279","article-title":"Sodium-activated potassium channels moderate excitability in vascular smooth muscle","volume":"597","author":"Li","year":"2019","journal-title":"J. Physiol."},{"key":"10.1016\/j.tips.2021.05.003_bb0060","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fncel.2016.00081","article-title":"Potassium channels and human epileptic phenotypes: an updated overview","volume":"10","author":"Villa","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.tips.2021.05.003_bb0065","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ana.24229","article-title":"Targeted treatment of migrating partial seizures of infancy with quinidine","volume":"76","author":"Bearden","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2021.05.003_bb0070","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1007\/s13311-018-0657-9","article-title":"Early treatment with quinidine in 2 patients with epilepsy of infancy with migrating focal seizures (EIMFS) due to gain-of-function KCNT1 mutations: functional studies, clinical responses, and critical issues for personalized therapy","volume":"15","author":"Dilena","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.tips.2021.05.003_bb0075","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s13311-019-00739-y","article-title":"Treatment responsiveness in KCNT1-related epilepsy","volume":"16","author":"Fitzgerald","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.tips.2021.05.003_bb0080","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.braindev.2017.09.008","article-title":"A quinidine non responsive novel KCNT1 mutation in an Indian infant with epilepsy of infancy with migrating focal seizures","volume":"40","author":"Madaan","year":"2018","journal-title":"Brain and Dev."},{"key":"10.1016\/j.tips.2021.05.003_bb0085","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1212\/WNL.0000000000004762","article-title":"Clinical and molecular characterization of KCNT1-related severe early-onset epilepsy","volume":"90","author":"McTague","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.tips.2021.05.003_bb0090","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/ana.24520","article-title":"Quinidine in the treatment of KCNT1-positive epilepsies","volume":"78","author":"Mikati","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2021.05.003_bb0095","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1212\/WNL.0000000000004769","article-title":"Precision therapy for epilepsy due to KCNT1 mutations: a randomized trial of oral quinidine","volume":"90","author":"Mullen","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.tips.2021.05.003_bb0100","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1111\/epi.14551","article-title":"Lack of response to quinidine in KCNT1-related neonatal epilepsy","volume":"59","author":"Numis","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.tips.2021.05.003_bb0105","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.curtheres.2019.02.002","article-title":"Concurrent quinidine and penobarbital in the treatment of a patient with 2 KCNT1 mutations","volume":"90","author":"Passey","year":"2019","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"10.1016\/j.tips.2021.05.003_bb0110","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4103\/aian.AIAN_229_18","article-title":"Two South Indian children with KCNT1-related malignant migrating focal seizures of infancy \u2013 clinical characteristics and outcome of targeted treatment with quinidine","volume":"22","author":"Patil","year":"2019","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.tips.2021.05.003_bb0115","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.braindev.2020.05.002","article-title":"KCNT1-positive epilepsy of infancy with migrating focal seizures successfully treated with nonnarcotic antitussive drugs after treatment failure with quinidine: a case report","volume":"42","author":"Takase","year":"2020","journal-title":"Brain and Dev."},{"key":"10.1016\/j.tips.2021.05.003_bb0120","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1684\/epd.2019.1026","article-title":"Quinidine therapy and therapeutic drug monitoring in four patients with KCNT1 mutations","volume":"21","author":"Yoshitomi","year":"2019","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.tips.2021.05.003_bb0125","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-231178","article-title":"Infantile refractory seizures due to de novo KCNT 1 mutation","volume":"12","author":"Alsaleem","year":"2019","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.tips.2021.05.003_bb0130","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fneur.2019.00064","article-title":"Quinidine therapy for Lennox\u2013Gastaut syndrome with KCNT1 mutation. A case report and literature review","volume":"10","author":"Jia","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.tips.2021.05.003_bb0135","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cell.2016.12.030","article-title":"Structural titration of Slo2.2, a Na+-dependent K+ channel","volume":"168","author":"Hite","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.tips.2021.05.003_bb0140","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/ng.2441","article-title":"De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy","volume":"44","author":"Barcia","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tips.2021.05.003_bb0145","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/ng.2440","article-title":"Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy","volume":"44","author":"Heron","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tips.2021.05.003_bb0150","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1528-1157.1995.tb00961.x","article-title":"Migrating partial seizures in infancy: a malignant disorder with developmental arrest","volume":"36","author":"Coppola","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.tips.2021.05.003_bb0155","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1111\/epi.13072","article-title":"De novo KCNT1 mutations in early-onset epileptic encephalopathy","volume":"56","author":"Ohba","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.tips.2021.05.003_bb0160","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.celrep.2014.11.015","article-title":"Human slack potassium channel mutations increase positive cooperativity between individual channels","volume":"9","author":"Kim","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2021.05.003_bb0165","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1111\/epi.13071","article-title":"Mutations in KCNT1 cause a spectrum of focal epilepsies","volume":"56","author":"M\u00f8ller","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.tips.2021.05.003_bb0170","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/acn3.50847","article-title":"Functional consequences of a KCNT1 variant associated with status dystonicus and early-onset infantile encephalopathy","volume":"6","author":"Gertler","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.tips.2021.05.003_bb0175","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neuroscience.2017.03.035","article-title":"The Phe932Ile mutation in KCNT1 channels associated with severe epilepsy, delayed myelination and leukoencephalopathy produces a loss-of-function channel phenotype","volume":"351","author":"Evely","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.tips.2021.05.003_bb0180","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pediatrneurol.2013.06.024","article-title":"Identification of a novel de novo p.Phe932Ile KCNT1 mutation in a patient with leukoencephalopathy and severe epilepsy","volume":"50","author":"Vanderver","year":"2014","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.tips.2021.05.003_bb0185","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jpeds.2017.08.057","article-title":"Three cases of KCNT1 mutations: malignant migrating partial seizures in infancy with massive systemic to pulmonary collateral arteries","volume":"191","author":"Kawasaki","year":"2017","journal-title":"J. Pediatr."},{"key":"10.1016\/j.tips.2021.05.003_bb0190","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1017\/S1047951120002735","article-title":"Cardiac phenotypic spectrum of KCNT1 mutations","volume":"30","author":"Kohli","year":"2020","journal-title":"Cardiol. Young"},{"key":"10.1016\/j.tips.2021.05.003_bb0195","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/ped.14427","article-title":"Recurrent pulmonary hemorrhage in juvenile patients with KCNT1 mutation","volume":"63","author":"Ikeda","year":"2021","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.tips.2021.05.003_bb0200","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0896-6273(03)00096-5","article-title":"The sodium-activated potassium channel is encoded by a member of the Slo gene family","volume":"37","author":"Yuan","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2021.05.003_bb0205","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nrn1992","article-title":"High-conductance potassium channels of the SLO family","volume":"7","author":"Salkoff","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tips.2021.05.003_bb0210","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nature14958","article-title":"Cryo-electron microscopy structure of the Slo2.2 Na+-activated K+ channel","volume":"527","author":"Hite","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.tips.2021.05.003_bb0215","doi-asserted-by":"crossref","first-page":"354262","DOI":"10.1155\/2013\/354262","article-title":"Slack, Slick and sodium-activated potassium channels","volume":"2013","author":"Kaczmarek","year":"2013","journal-title":"ISRN Neurosci."},{"key":"10.1016\/j.tips.2021.05.003_bb0220","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1523\/JNEUROSCI.0859-09.2009","article-title":"NAD+ activates KNa channels in dorsal root ganglion neurons","volume":"29","author":"Tamsett","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2021.05.003_bb0225","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.tins.2005.06.003","article-title":"For K+ channels, Na+ is the new Ca2+","volume":"28","author":"Bhattacharjee","year":"2005","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tips.2021.05.003_bb0230","doi-asserted-by":"crossref","first-page":"7554","DOI":"10.1523\/JNEUROSCI.0525-10.2010","article-title":"The RCK2 domain uses a coordination site present in Kir channels to confer sodium sensitivity to Slo2.2 channels","volume":"30","author":"Zhang","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2021.05.003_bb0235","doi-asserted-by":"crossref","first-page":"14528","DOI":"10.1074\/jbc.M115.653089","article-title":"Identification of the intracellular Na+ sensor in Slo2.1 potassium channels","volume":"290","author":"Thomson","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2021.05.003_bb0240","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1113\/JP273225","article-title":"Molecular mechanisms of Slo2 K+ channel closure","volume":"595","author":"Giese","year":"2017","journal-title":"J. Physiol."},{"key":"10.1016\/j.tips.2021.05.003_bb0245","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1085\/jgp.201311064","article-title":"Structural basis of ion permeation gating in Slo2.1 K+ channels","volume":"142","author":"Garg","year":"2013","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.tips.2021.05.003_bb0250","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.1038\/s41467-019-13227-w","article-title":"Molecular mechanism of a potassium channel gating through activation gate-selectivity filter coupling","volume":"10","author":"Kopec","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2021.05.003_bb0255","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1074\/jbc.RA119.010612","article-title":"Selectivity filter instability dominates the low intrinsic activity of the TWIK-1 K2P K","volume":"295","author":"Nematian-Ardestani","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2021.05.003_bb0260","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.cell.2016.02.002","article-title":"A non-canonical voltage-sensing mechanism controls gating in K2P K+ channels","volume":"164","author":"Schewe","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.tips.2021.05.003_bb0265","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nature22988","article-title":"K2P2.1(TREK-1):activator complexes reveal a cryptic selectivity filter binding site","volume":"547","author":"Lolicato","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.tips.2021.05.003_bb0270","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/ana.24128","article-title":"KCNT1 gain of function in 2 epilepsy phenotypes is reversed by quinidine","volume":"75","author":"Milligan","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2021.05.003_bb0275","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mcn.2016.01.004","article-title":"Characterization of two de novoKCNT1 mutations in children with malignant migrating partial seizures in infancy","volume":"72","author":"Rizzo","year":"2016","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.tips.2021.05.003_bb0280","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.celrep.2015.12.019","article-title":"Epilepsy-related Slack channel mutants lead to channel over-activity by two different mechanisms","volume":"14","author":"Tang","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2021.05.003_bb0285","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.celrep.2016.07.024","article-title":"Stimulation of Slack K+ channels alters mass at the plasma membrane by triggering dissociation of a phosphatase-regulatory complex","volume":"16","author":"Fleming","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2021.05.003_bb0290","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1096\/fj.201902366R","article-title":"Phactr1 regulates Slack (KCNT1) channels via protein phosphatase 1 (PP1)","volume":"34","author":"Ali","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.tips.2021.05.003_bb0295","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1093\/hmg\/ddu030","article-title":"Clinical whole-genome sequencing in severe early-onset epilepsy reveals new genes and improves molecular diagnosis","volume":"23","author":"Martin","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tips.2021.05.003_bb0300","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.neuropharm.2006.06.003","article-title":"Pharmacological activation and inhibition of Slack (Slo2.2) channels","volume":"51","author":"Yang","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tips.2021.05.003_bb0305","doi-asserted-by":"crossref","first-page":"101100","DOI":"10.1016\/j.isci.2020.101100","article-title":"Structure-based identification and characterization of inhibitors of the epilepsy-associated KNa1.1 (KCNT1) potassium channel","volume":"23","author":"Cole","year":"2020","journal-title":"IScience"},{"key":"10.1016\/j.tips.2021.05.003_bb0310","first-page":"465","article-title":"Clofilium inhibits Slick and Slack potassium channels","volume":"6","author":"de Los Angeles Tejada","year":"2012","journal-title":"Biologics"},{"key":"10.1016\/j.tips.2021.05.003_bb0315","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/epi.16480","article-title":"KCNT1-related epilepsy: an international multicenter cohort of 27 pediatric cases","volume":"61","author":"Borlot","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.tips.2021.05.003_bb0320","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0002-8703(80)90148-9","article-title":"Entry of quinidine into cerebrospinal fluid","volume":"100","author":"Ochs","year":"1980","journal-title":"Am. Heart J."},{"key":"10.1016\/j.tips.2021.05.003_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2017.11.017","article-title":"Does age affect response to quinidine in patients with KCNT1 mutations? Report of three new cases and review of the literature","volume":"55","author":"Abdelnour","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.tips.2021.05.003_bb0330","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0022-3565(24)35139-0","article-title":"Bepridil blunts the shortening of action potential duration caused by metabolic inhibition via blockade of ATP-sensitive K+ channels and Na+-activated K+ channels","volume":"291","author":"Li","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2021.05.003_bb0335","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/sj.bjp.0704784","article-title":"Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine","volume":"136","author":"Paul","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2021.05.003_bb0340","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejphar.2004.07.019","article-title":"Acquired QT interval prolongation and HERG: implications for drug discovery and development","volume":"500","author":"Finlayson","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tips.2021.05.003_bb0345","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41598-017-18448-x","article-title":"Probing the molecular basis of hERG drug block with unnatural amino acids","volume":"8","author":"Macdonald","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2021.05.003_bb0350","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1124\/mol.105.020990","article-title":"Molecular determinants of HERG channel block","volume":"69","author":"Kamiya","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tips.2021.05.003_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028778","article-title":"In silico analysis of conformational changes induced by mutation of aromatic binding residues: consequences for drug binding in the hERG K+ channel","volume":"6","author":"Knape","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tips.2021.05.003_bb0360","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1124\/mol.104.000117","article-title":"Structural determinants of HERG channel block by clofilium and ibutilide","volume":"66","author":"Perry","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tips.2021.05.003_bb0365","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1021\/acschemneuro.0c00583","article-title":"VU0606170, a selective Slack channels inhibitor, decreases calcium oscillations in cultured cortical neurons","volume":"11","author":"Spitznagel","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.tips.2021.05.003_bb0370","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1021\/acsmedchemlett.0c00675","article-title":"Discovery of the first orally available, selective KNa1.1 inhibitor: in vitro and in vivo activity of an oxadiazole series","volume":"12","author":"Griffin","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.tips.2021.05.003_bb0375","doi-asserted-by":"crossref","first-page":"15318","DOI":"10.1523\/JNEUROSCI.2162-12.2012","article-title":"Regulation of neuronal excitability by interaction of fragile X mental retardation protein with slack potassium channels","volume":"32","author":"Zhang","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2021.05.003_bb0380","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/nn.3468","article-title":"TMEM16C facilitates Na+-activated K+ currents in rat sensory neurons and regulates pain processing","volume":"16","author":"Huang","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tips.2021.05.003_bb0385","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.53986","article-title":"Slo2 potassium channel function depends on RNA editing-regulated expression of a SCYL1 protein","volume":"9","author":"Niu","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.tips.2021.05.003_bb0390","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1085\/jgp.201411259","article-title":"Paxilline inhibits BK channels by an almost exclusively closed-channel block mechanism","volume":"144","author":"Zhou","year":"2014","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.tips.2021.05.003_bb0395","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1085\/jgp.20028605","article-title":"Coupling between voltage sensor activation, Ca2+ binding and channel opening in large conductance (BK) potassium channels","volume":"120","author":"Horrigan","year":"2002","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.tips.2021.05.003_bb0400","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/epi.16834","article-title":"In silico model reveals the key role of GABA in KCNT1-epilepsy in infancy with migrating focal seizures","volume":"62","author":"Kuchenbuch","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.tips.2021.05.003_bb0405","doi-asserted-by":"crossref","first-page":"108303","DOI":"10.1016\/j.celrep.2020.108303","article-title":"Reduced GABAergic neuron excitability, altered synaptic connectivity, and seizures in a KCNT1 gain-of-function mouse model of childhood epilepsy","volume":"33","author":"Shore","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2021.05.003_bb0410","doi-asserted-by":"crossref","first-page":"7438","DOI":"10.1523\/JNEUROSCI.1628-18.2019","article-title":"An epilepsy-associated KCNT1 mutation enhances excitability of human iPSC-derived neurons by increasing Slack KNa currents","volume":"39","author":"Quraishi","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2021.05.003_bb0415","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1038\/s41598-020-60028-z","article-title":"Impaired motor skill learning and altered seizure susceptibility in mice with loss or gain of function of the Kcnt1 gene encoding Slack (KNa1.1) Na+-activated K+ channels","volume":"10","author":"Quraishi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2021.05.003_bb0420","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1177\/0883073819854853","article-title":"Two patients with KCNT1-related epilepsy responding to phenobarbital and potassium bromide","volume":"34","author":"Datta","year":"2019","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.tips.2021.05.003_bb0425","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.seizure.2019.02.019","article-title":"Migrating focal seizures in autosomal dominant sleep-related hypermotor epilepsy with KCNT1 mutation","volume":"67","author":"Cataldi","year":"2019","journal-title":"Seizure"}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614721000985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614721000985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T09:11:59Z","timestamp":1759050719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614721000985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":85,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0165614721000985"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2021.05.003","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting KNa1.1 channels in KCNT1-associated epilepsy","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2021.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}